001     180695
005     20240229145629.0
024 7 _ |a 10.1038/s43018-022-00420-y
|2 doi
024 7 _ |a pmid:35840692
|2 pmid
037 _ _ |a DKFZ-2022-01491
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Walle, Thomas
|0 P:(DE-He78)51635089578f68fc9efdb61e6a760b64
|b 0
|e First author
245 _ _ |a Author Correction: Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy.
260 _ _ |a London
|c 2022
|b Nature Research
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1698997853_23208
|2 PUB:(DE-HGF)
|x Erratum/Correction
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:F230#LA:F230# / 2022 Sep;3(9):1137 / HI-TRON
536 _ _ |a 316 - Infektionen, Entzündung und Krebs (POF4-316)
|0 G:(DE-HGF)POF4-316
|c POF4-316
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Bajaj, Sunanjay
|0 P:(DE-HGF)0
|b 1
|e First author
700 1 _ |a Kraske, Joscha A
|0 P:(DE-He78)7fb0841f5e88928308e29474e3170818
|b 2
|u dkfz
700 1 _ |a Rösner, Thomas
|b 3
700 1 _ |a Cussigh, Christiane S
|b 4
700 1 _ |a Kälber, Katharina A
|b 5
700 1 _ |a Müller, Lisa Jasmin
|b 6
700 1 _ |a Strobel, Sophia Boyoung
|b 7
700 1 _ |a Burghaus, Jana
|b 8
700 1 _ |a Kallenberger, Stefan M
|b 9
700 1 _ |a Stein-Thöringer, Christoph
|0 P:(DE-He78)c65b1d3644b08872d944d3cd069737ce
|b 10
700 1 _ |a Jenzer, Maximilian
|b 11
700 1 _ |a Schubert, Antonia
|0 P:(DE-He78)83ba3db324720df82864fa5c863fec08
|b 12
700 1 _ |a Kahle, Steffen
|b 13
700 1 _ |a Williams, Anja
|b 14
700 1 _ |a Hoyler, Birgit
|0 P:(DE-He78)25e88e7894cbce24806666301288f7e5
|b 15
700 1 _ |a Zielske, Lin
|b 16
700 1 _ |a Skatula, Renate
|b 17
700 1 _ |a Sawall, Stefanie
|0 P:(DE-He78)7f98cc11197c11a7645e4c8e1dba83a4
|b 18
700 1 _ |a Leber, Mathias Felix
|0 P:(DE-He78)1401445b374879f90e840ca2e6a96bac
|b 19
700 1 _ |a Kunes, Russell Z
|b 20
700 1 _ |a Krisam, Johannes
|b 21
700 1 _ |a Fremd, Carlo
|b 22
700 1 _ |a Schneeweiss, Andreas
|b 23
700 1 _ |a Krauss, Jürgen
|b 24
700 1 _ |a Apostolidis, Leonidas
|b 25
700 1 _ |a Berger, Anne Katrin
|b 26
700 1 _ |a Haag, Georg Martin
|0 P:(DE-He78)f54d0426f2215c539d3a7ae1b400b57d
|b 27
700 1 _ |a Zschäbitz, Stefanie
|b 28
700 1 _ |a Halama, Niels
|0 P:(DE-He78)0a4053be7ffd6aa9bef69de28753a601
|b 29
700 1 _ |a Springfeld, Christoph
|b 30
700 1 _ |a Kirsten, Romy
|b 31
700 1 _ |a Hassel, Jessica
|0 P:(DE-He78)00858755eb8a7861491b50e2d00e52f1
|b 32
700 1 _ |a Jäger, Dirk
|0 P:(DE-He78)ed0321409c9cde20b380ae663dbcefd1
|b 33
700 1 _ |a Investigators, NCT ANTICIPATE
|b 34
|e Collaboration Author
700 1 _ |a Ungerechts, Guy
|0 P:(DE-He78)833f90e2abdd29594ad5c4f08600f191
|b 35
|e Last author
700 1 _ |a Abdelrahim, Omar
|b 36
700 1 _ |a Busch, Elena
|b 37
700 1 _ |a Derigs, Patrick
|b 38
700 1 _ |a Dischinger, Katharina
|b 39
700 1 _ |a Mitri, Fouad
|b 40
700 1 _ |a Schmidt, Kerstin
|b 41
700 1 _ |a Bhatti, Irfan A
|b 42
700 1 _ |a Grün, Barbara
|b 43
700 1 _ |a Hohmann, Nicolas
|b 44
700 1 _ |a Woydack, Lena
|b 45
700 1 _ |a Zhang, Xin-Wen
|b 46
700 1 _ |a Ferber, Dyke
|b 47
700 1 _ |a Mock, Andreas
|b 48
700 1 _ |a Pompecki, Tillmann
|b 49
700 1 _ |a Schank, Timo
|b 50
700 1 _ |a Fremd, Carlo
|b 51
700 1 _ |a Haag, Georg M
|b 52
700 1 _ |a Halama, Niels
|b 53
700 1 _ |a Kirsten, Romy
|b 54
700 1 _ |a Hassel, Jessica C
|b 55
700 1 _ |a Jäger, Dirk
|b 56
773 _ _ |a 10.1038/s43018-022-00420-y
|0 PERI:(DE-600)3005299-3
|n 9
|p 1137
|t Nature cancer
|v 3
|y 2022
|x 2662-1347
909 C O |p VDB
|o oai:inrepo02.dkfz.de:180695
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)51635089578f68fc9efdb61e6a760b64
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)7fb0841f5e88928308e29474e3170818
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 10
|6 P:(DE-He78)c65b1d3644b08872d944d3cd069737ce
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)83ba3db324720df82864fa5c863fec08
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 15
|6 P:(DE-He78)25e88e7894cbce24806666301288f7e5
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 P:(DE-He78)7f98cc11197c11a7645e4c8e1dba83a4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 19
|6 P:(DE-He78)1401445b374879f90e840ca2e6a96bac
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 27
|6 P:(DE-He78)f54d0426f2215c539d3a7ae1b400b57d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 29
|6 P:(DE-He78)0a4053be7ffd6aa9bef69de28753a601
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 32
|6 P:(DE-He78)00858755eb8a7861491b50e2d00e52f1
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 33
|6 P:(DE-He78)ed0321409c9cde20b380ae663dbcefd1
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 35
|6 P:(DE-He78)833f90e2abdd29594ad5c4f08600f191
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-316
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Infektionen, Entzündung und Krebs
|x 0
914 1 _ |y 2022
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT CANCER : 2021
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-08
915 _ _ |a IF >= 20
|0 StatID:(DE-HGF)9920
|2 StatID
|b NAT CANCER : 2021
|d 2022-11-08
920 2 _ |0 I:(DE-He78)F230-20160331
|k F230
|l KKE Virotherapie
|x 0
920 1 _ |0 I:(DE-He78)F230-20160331
|k F230
|l KKE Virotherapie
|x 0
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 1
920 1 _ |0 I:(DE-He78)E055-20160331
|k E055
|l E055 KKE Molekulare Radioonkologie
|x 2
920 1 _ |0 I:(DE-He78)F220-20160331
|k F220
|l Mikrobiom und Krebs
|x 3
920 1 _ |0 I:(DE-He78)B110-20160331
|k B110
|l B110 Signalwege funktionelle Genomik
|x 4
920 1 _ |0 I:(DE-He78)D120-20160331
|k D120
|l D120 Angewandte Tumor-Immunität
|x 5
920 1 _ |0 I:(DE-He78)D240-20160331
|k D240
|l Translationale Immuntherapie
|x 6
920 0 _ |0 I:(DE-He78)F230-20160331
|k F230
|l KKE Virotherapie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)F230-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a I:(DE-He78)E055-20160331
980 _ _ |a I:(DE-He78)F220-20160331
980 _ _ |a I:(DE-He78)B110-20160331
980 _ _ |a I:(DE-He78)D120-20160331
980 _ _ |a I:(DE-He78)D240-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21